🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Biopsy

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery NCT07140172NA55 sites📍 Bethesda📍 Durham📍 Philadelphia University Hospital, Basel, Switzerland · Tests: Axillary lymph node dissection (ALND), Axillary radiotherapy (ART) Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer NCT07844473NA1 site📍 Madinah King Faisal Specialist Hospital & Research Center · Tests: Super paramagnetic iron oxide bracketing injection CtDNA Based MRD Testing for NAC Monitoring in TNBC NCT06230185n/a14 sites📍 Tucson📍 Aurora📍 Washington D.C. Personalis Inc. Validation of the Oncoliq Test for the Early Detection of Breast Cancer. NCT07331506n/a1 site📍 Buenos Aires Oncoliq US Inc · Tests: Peripheral blood draw Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer NCT07570524n/a1 site📍 Rennes Center Eugene Marquis · Tests: Additionnal breast biospy and blood sample Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB) NCT04293796NA1 site📍 Saint Petersburg N.N. Petrov National Medical Research Center of Oncology · Tests: Vacuum-assisted biopsy Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement NCT07278726n/a14 sites📍 Bologna📍 Forlì📍 Milan European Institute of Oncology · Tests: Upfront Targeted Axillary Dissection (UTAD) Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients NCT06780748Phase 21 site📍 Goyang-si National Cancer Center, Korea · Tests: Identification rate of sentinel lymph node Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer NCT00477100n/a10 sites📍 Gilbert📍 La Jolla📍 Greeley M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Interview, Medical Chart Review, Questionnaire Administration Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer NCT05601440Phase 210 sites📍 Calgary📍 Kelowna📍 Vancouver Canadian Cancer Trials Group · Tests: RP-6306, Gemcitabine, Observation, Niraparib, Fulvestrant Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction NCT06294574NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: HydroMARK Plus Clip IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases NCT06092892Phase 23 sites📍 Los Angeles📍 Pasadena📍 Tarzana Alice Chung · Tests: Breast Surgery (BCS or mastectomy) with TAD/SNB, Adjuvant Radiation Therapy A Multicenter Cancer Biospecimen Collection Study NCT04510129n/a1 site📍 San Francisco Cofactor Genomics, Inc. · Tests: OncoPrism™ assay Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients NCT04608357n/a1 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Needle Core Biopsies PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients NCT06610539n/a2 sites📍 Chapel Hill📍 Richmond Endomagnetics Ltd. Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST) NCT05505357NA1 site📍 Seoul Seoul National University Hospital · Tests: Breast surgery omission Biopsy-site-marker in Breast Cancer NCT07833566n/a1 site📍 Oklahoma City University of Oklahoma · Tests: Biopsy-Site Marker Placement. Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) NCT07327489n/a8 sites📍 Fort Smith📍 Frederick📍 Springfield Elephas · Tests: Biopsy Using a Blood Test to Monitor Metastatic Breast Cancer Treatment NCT05804578n/a2 sites📍 Kingston📍 Toronto Dr. Christopher Mueller Magseed Enabled Long-Term Localization of Axillary Lymph Nodes NCT03796559NA2 sites📍 Houston📍 Houston Endomagnetics Ltd. · Tests: Magseed Marker Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy NCT07558447NA1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: CIPN assessment, EV blood analysis Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA NCT07418125NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Liquid biopsy Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment NCT06087120n/a3 sites📍 Jakarta📍 Ho Chi Minh City📍 Ho Chi Minh City Gene Solutions Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC NCT07080944NA1 site📍 Milan European Institute of Oncology · Tests: SLN identification using technetium-99m, SLN intra-operatory identification with radioguided surgery, Axillary Limph No… CfDNA in Hereditary And High-risk Malignancies 2 NCT06726642n/a8 sites📍 Vancouver📍 St. John's📍 Halifax University Health Network, Toronto · Tests: Cell-free DNA analysis Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings NCT06268405NA1 site📍 Toronto University Health Network, Toronto · Tests: Liquid Biopsy, Positron Emission Mammography (PEM) ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation NCT05059444n/a57 sites📍 Birmingham📍 Chandler📍 Hot Springs Guardant Health, Inc. · Tests: Guardant Reveal Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence NCT04741737NA1 site📍 Seoul Gangnam Severance Hospital · Tests: reSLNB arm Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ NCT04722692Phase 39 sites📍 Houston📍 Hong Kong📍 Falun Uppsala University · Tests: Delayed SLND, Late SLND A Prospective Multicenter Study of the TuFEst-LN Model for Axillary Lymph Node Status Assessment in Breast Cancer NCT07304934n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: No Intervention: Observational Cohort
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy